We chatted to IronRidge Resources' CEO Vincent Mascolo who explains why the company has become a lithium explorer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMereo Biopharma Share News (MPH)

  • There is currently no data for MPH

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Mereo BioPharma Withdraws US Listing Application On OncoMed Deal (ALLIPO)

LONDON (Alliance News) - Mereo BioPharma Group PLC said Friday it has requested the withdrawal of its US IPO application as it continues to work on its business combination with US pharmaceutical

22 Feb 19 14:35

Mereo BioPharma Founding Director Departs Before OncoMed Combination

LONDON (Alliance News) - Mereo BioPharma Group PLC on Monday announced the immediate departure of founding board director Frank Armstrong prior to Mereo's combination with US firm OncoMed was

11 Feb 19 12:44

Scancell Appoints New Head Of Research And Manufacturing Divisions

LONDON (Alliance News) - Scancell Holdings PLC on Monday said it appointed two new executives as head of research and head of manufacturing.Samantha Paston joined Scancell as head of in She

21 Jan 19 12:58

Mereo BioPharma To Acquire US Oncology Firm In All Stock Deal

LONDON (Alliance News) - Mereo BioPharma Group PLC on Wednesday said it will buy US oncology-focused clinical stage biopharmaceutical business OncoMed Pharmaceuticals Inc via a all-stock deal at a

5 Dec 18 14:33

Mereo BioPharma Doses First Patient In Phase Two MPH-966 Study

LONDON (Alliance News) - Rare disease pharmaceutical company Mereo Biopharma Group PLC said on Monday it has has dosed its first patient in its Phase 2 clinical study of MPH-966, which is for the

5 Nov 18 12:26

Mereo Completes Patient Enrolment In Brittle Bone Disease Drug Trial

LONDON (Alliance News) - Mereo Biopharma Group PLC on Monday said it has completed patient enrolment in its phase 2b clinical study of its drug BPS-804, or Setrusumab, which is being conducted in

15 Oct 18 11:20

Mereo BioPharma Completes Positive Revision Of Credit Facility Terms (ALLISS)

LONDON (Alliance News) - Mereo BioPharma Group PLC said Monday that it completed a revision of the terms of its credit facility with Silicon Valley Bank and Kreos Capital.The revised terms

1 Oct 18 13:15

Mereo BioPharma Considering Fundraise As Interim Loss Narrows

LONDON (Alliance News) - Mereo BioPharma Group PLC said Wednesday it continues to make progress on "all fronts" after narrowing its interim loss.For the six months to June 30, the

8 Aug 18 12:53

UK Shareholder Meetings Calendar - Next 7 Days

Friday 15 JuneJD Sports Fashion (re acquisition of The Finish Line)MP Evans GroupBaker Steel 18 (re 19

14 Jun 18 14:40

Mereo BioPharma Looks To Broaden Shareholder Base (ALLISS)

LONDON (Alliance News) - Mereo BioPharma Group PLC said Tuesday it placed 50,076 shares at 300 pence each.Following admission to trading of the new shares, which is expected to occur on 1,

29 May 18 12:31

Mereo BioPharma Halts Listing On Nasdaq Due To Market Conditions (ALLIPO)

LONDON (Alliance News) - Mereo BioPharma Group PLC said on Thursday it has decided to postpone its proposed listing of American depository shares on the Nasdaq Global Market.Mereo said the

26 Apr 18 13:36

Mereo BioPharma Hails Positive BGS-649 Phase II Clinical Trial Data

LONDON (Alliance News) - Mereo BioPharma Group PLC said Monday it had received positive top-line data for its phase II clinical trial for hypogonadotropic hypogonadism in said

19 Mar 18 13:14

Diurnal Hires Outgoing Mereo BioPharma Finance Chief Bungay

12 Jan 17 09:04

Mereo Biopharma Progresses Drug Candidates In Maiden Interim Period

16 Sep 16 10:15

UK Shareholder Meetings Calendar - Next 7 Days

11 Jul 16 15:07

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.